Stocks

Charles River Labs Slips 0.84% but Holds Strong 30-Day Gain of Nearly 12%

CRL shares edged lower Friday while still reflecting substantial monthly momentum for the contract research organization.

By Love Wallet · November 14, 2026

Charles River Labs Slips 0.84% but Holds Strong 30-Day Gain of Nearly 12%
Price
$337.95
24h
-0.84%
1 week
+0.21%
1 month
+11.89%
Market cap
$16.33B

Charles River Laboratories International, Inc. (CRL) closed at $337.95 on November 14, 2026, a decline of 0.84% over the prior 24 hours. The modest pullback came despite a broadly positive medium-term trend for the stock.

Over the past seven days, shares have added 0.21%, suggesting the recent session's dip did not meaningfully disrupt the stock's near-term stability. The more notable figure comes from the 30-day window, where CRL has risen 11.89%, pointing to a sustained period of buying interest.

The company's market capitalization stands at $16.33 billion, reflecting its position as a significant player in the contract research and preclinical services sector. The single-session decline appeared limited in scope relative to the broader gains accumulated over the past month.

With a 30-day advance of nearly 12% now on record, Friday's pullback represents a relatively minor fluctuation within what has been a strong stretch of performance for Charles River Laboratories shares.

Market data is provided for informational purposes only and may be delayed. Nothing in this article is financial advice.

Track Charles River Laboratories International, Inc. and your whole portfolio with Love Wallet.

Get started free